<DOC>
	<DOCNO>NCT00768261</DOCNO>
	<brief_summary>The overall purpose research determine relationship symptom Dementia Alzheimers type change size shape certain brain structure combine Donepezil ( Aricept® ) Memantine ( Namenda® ) treatment .</brief_summary>
	<brief_title>Corticolimbic Degeneration Treatment Dementia</brief_title>
	<detailed_description>In study use Memantine ( Namenda® ) investigational fashion individual mild mild dementia . Donepezil ( Aricept® ) approve Food Drug Administration treatment Alzheimers disease . Memantine ( Namenda® ) currently approve Food Drug Administration moderate severe dementia . This study may instrumental development new therapy others similar condition , determine whether Memantine ( Namenda® ) helpful individual mild mild dementia . Specific Aim 1 . To determine neuroanatomical measure strongly correlate progression clinical cognitive deficit patient dementia Alzheimer type ( DAT ) . To accomplish aim , use high-resolution magnetic resonance ( MR ) imaging tool computational anatomy ass change structure select subcortical ( e.g. , hippocampus ) cortical ( e.g. , parahippocampal gyrus cingulate gyrus ) structure along clinical cognitive measure dementia severity subject mild-to-mild DAT . Specific Aim 2 - To determine whether cholinesterase inhibitor memantine slow disease progression DAT subject . To accomplish aim , use MR imaging tool computational anatomy compare rate change neuroanatomical measure list 1 ) untreated DAT subject , 2 ) DAT subject treat donepezil alone , 3 ) DAT subject treat combination donepezil memantine .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Memantine</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>1 ) meet NINCDSADRDA criterion DAT , 2 ) CDR score 0.5 1 , 3 ) 5080 year age , 4 ) able give inform consent primary caregiver legal guardian , give informed consent . 1 ) psychiatric ( e.g. , depression ) neurological ( e.g. , CVA ) disorder would confound assessment dementia symptom , 2 ) history loss consciousness , 3 ) unstable severe medical illness ( e.g. , hepatotoxicity ) would make donepezil memantine treatment participation aspect study unsafe .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Dementia Alzheimer type</keyword>
</DOC>